U.S. Oil and Gas Stock News

Bristol-Myers Squibb (BMY) is back in focus after the European Commission approved Opdivo plus AVD as the first immunotherapy-based frontline regimen for advanced Hodgkin lymphoma in the EU, alongside strong new Phase 3 oncology data. See our latest analysis for Bristol-Myers Squibb. Recent oncology updates, including the new EU approval for Opdivo plus AVD, come as the stock shows a 7.13% year to date share price return and a 24.21% one year total shareholder return. However, shorter term...

ZenaTech (ZENA) is back in focus after reporting first quarter 2026 results that paired record CAD 8.4 million revenue with a wider CAD 26.55 million net loss, highlighting the trade off between growth investments and current profitability. See our latest analysis for ZenaTech. The stock’s recent momentum has cooled, with the share price down 11.18% over the last day and 56.87% year to date, while the 1 year total shareholder return has fallen 68.53%. This suggests that heavy investment...

Energy Vault Holdings (NYSE:NRGV) agreed to acquire an 850 MW battery energy storage development portfolio in Japan from BayWa r.e. AG. The deal marks NRGV's entry into Japan, adding a large set of battery projects to its global pipeline. The portfolio consists of large scale battery energy storage system projects across key Japanese power markets. Energy Vault focuses on energy storage solutions that support grid reliability and renewable power integration. This move into Japan aligns with...

If you are wondering whether Empire State Realty Trust at US$5.27 is a bargain or a value trap, the key is to look closely at what the current price actually implies. The stock has been under pressure, with the share price down 8.0% over the past week, 7.1% over the past month, 18.5% year to date, and 36.0% over the last year. These moves can change how investors think about both upside potential and risk. Recent coverage around office real estate and investor sentiment toward Office REITs...

Everest Group stock snapshot after recent performance shifts Everest Group (EG) has seen mixed share performance recently, with the stock up 4.7% over the past day and 3.2% over the past week, but down 5.0% over the past month. See our latest analysis for Everest Group. Zooming out, Everest Group’s recent rebound sits against a flatter backdrop, with the 1 year total shareholder return slightly lower at 1.6% and the 5 year total shareholder return at 46.0%, which hints that momentum has...

Commerce Trust has gone live on SS&C Advent’s Genesis platform, using SS&C Technologies Holdings’ cloud-native, AI-enabled system for integrated investment operations. The go-live adds to a reported group of more than 30 firms implementing Genesis since 2024. The move highlights growing interest in unified, modern investment management platforms that combine operations, data and analytics. For investors tracking SS&C Technologies Holdings (NasdaqGS:SSNC), the Commerce Trust launch puts...

In late May 2026, Ingredion Incorporated announced a joint venture and 9% equity stake in India-based Sanstar Limited while also acquiring Benicaros, a patented prebiotic fiber made from upcycled carrot pomace, expanding its presence in pharmaceutical and specialty food ingredients and enhancing its health-focused product portfolio. These moves deepen Ingredion’s capabilities in clean-label, science-led specialty ingredients, combining local Indian manufacturing with proprietary...

Nektar Therapeutics (NKTR) has drawn attention after recent trading saw the stock fall 3.4% in a day and 11.7% over the past week, prompting investors to reassess this US-based biopharmaceutical company. See our latest analysis for Nektar Therapeutics. While Nektar Therapeutics’ share price has fallen 11.7% over the past week and 32.6% over the past month, the year to date share price return of 32% and a very large 1 year total shareholder return suggest earlier momentum is now fading as...

The Pennsylvania Public Utility Commission has approved PPL Electric Utilities’ settlement for a 3.23% distribution rate increase, effective July 1, supporting investments in grid reliability, resilience, and enhanced customer protections following broad stakeholder agreement. This outcome gives PPL greater regulatory clarity and a clearer path to fund its planned infrastructure upgrades while maintaining affordability programs for customers. Next, we’ll examine how this approved rate...

Clearwater Analytics Holdings (NYSE:CWAN) has launched a new suite of AI-enabled investment data products for institutional investors. The offerings, branded as Clearwater Compass, Total Portfolio Oversight, and Fund Analytics, target operations, risk, and private market workflows. The new tools are designed to automate data handling, improve portfolio transparency, and extend coverage into private markets. Clearwater Analytics Holdings, which trades at $24.37 under ticker NYSE:CWAN, is...

Wave Life Sciences' obesity candidate WVE-007 did not show meaningful improvement in recent clinical data. Following the data release, institutional investor Exome Asset Management exited its entire position in NasdaqGM:WVE. The setback affects Wave Life Sciences' obesity efforts and adds pressure to its broader development pipeline. For investors watching NasdaqGM:WVE, this update comes in the context of a share price of $5.73 and a year-to-date return that is down 64.1%. The stock has...

TriCo Bancshares (TCBK) is drawing fresh attention as investors weigh its recent share performance against underlying fundamentals, including revenue of US$415.928 million and net income of US$128.88 million from its U.S. focused banking operations. See our latest analysis for TriCo Bancshares. At a latest share price of US$50.69, TriCo Bancshares has seen short term share price returns cool slightly, while its 1 year total shareholder return of 29.63% and 3 year total shareholder return of...

Syndax Pharmaceuticals stock: event driven snapshot Syndax Pharmaceuticals (SNDX) has been drawing investor attention after recent trading performance, with the stock down 16% over the past month and 21% over the past 3 months from a last close of US$17.34. See our latest analysis for Syndax Pharmaceuticals. The recent weakness, including a 3.77% 1 day and 11.49% 7 day share price decline, has pulled year to date share price returns to a fall of 18.59%. However, the 1 year total shareholder...

Meritage Homes stock snapshot Meritage Homes (MTH) has drawn investor attention after a period of steady trading, with the stock recently closing at $68.33. The company reports annual revenue of $5,616.498m and net income of $385.516m. See our latest analysis for Meritage Homes. Recent trading points to gradually improving momentum, with a 7 day share price return of 4.74% and a 30 day share price return of 5.35%, while the 1 year total shareholder return of 9.57% reflects a steadier longer...

Voya Financial stock moves after recent performance shift Voya Financial (VOYA) has drawn fresh attention after a recent performance shift, with the stock showing moves over the past week, month and past 3 months that stand out against its recent history. See our latest analysis for Voya Financial. At a share price of $86.69, Voya Financial’s recent 1-day share price return of 3.28% builds on a 90-day share price return of 28.03%, while the 1-year total shareholder return of 33.25% reflects a...

Curbline Properties Corp. recently completed follow-on common stock offerings totaling about $120.27 million and launched a new at-the-market equity program to issue up to $400 million of additional shares for general corporate purposes. These moves significantly expand Curbline’s access to equity capital, offering flexibility to fund acquisitions, manage debt, and support its income-focused real estate portfolio. Next, we’ll examine how Curbline’s expanded US$400 million at-the-market...

Regions Financial recently expanded its homeownership support by offering free educational webinars, personalized mortgage guidance, and homebuyer education, while appointing veteran lender Todd Nelson to lead its home improvement financing business. Together with recognition for its treasury and retirement advisory capabilities, these moves highlight Regions’ push to deepen consumer relationships across housing, payments, and workplace retirement services. We’ll examine how Regions’...

In late May 2026, JetBlue announced plans to launch its first-ever nonstop service between Fort Lauderdale and Caracas, Venezuela, and unveiled a new Dominican Republic–themed Airbus A320 livery celebrating its deep ties with Dominican communities. Together with upgraded second-quarter revenue guidance that highlights robust travel demand and operational efficiency, these moves underscore JetBlue’s focus on strengthening Latin American connectivity and customer loyalty. Next, we’ll examine...

In the past few days, commentary on Ingersoll Rand has highlighted that its mission-critical flow creation business has delivered organic revenue growth below industry benchmarks over the last two years, with estimated sales growth of 3.1% for the next 12 months pointing to a potential demand slowdown. An additional concern is the company’s 6.1% return on capital, which raises questions about how effectively management is converting investments into profitable growth opportunities. We’ll now...

The FDA’s recent easing of safety screening requirements for Dianthus Therapeutics (DNTH) claseprubart trials has reshaped the setup for this autoimmune drug candidate, with investors now reassessing timing, risk and potential value in the stock. See our latest analysis for Dianthus Therapeutics. Despite the regulatory tailwind, the stock has recently cooled, with a 7 day share price return down 13.44% and a 30 day share price return down 10.96%. This follows a strong year to date share price...

Recent share performance and business context Rocket Companies (RKT) stock has pulled back, with the price closing at US$12.65 and declines of about 4% over the past day, 13% over the past week, and 15% over the past month. Over the past 3 months, the stock is down about 15%, while the year to date move shows a decline of roughly 36%. Over the past year the total return is slightly lower, in contrast with a much stronger 3 year total return figure. The company reports revenue of US$8.9b and...

Walker & Dunlop stock moves after recent performance data Walker & Dunlop (WD) has drawn fresh attention after recent share price moves. The stock is down 12.7% year to date and 21.3% over the past year, despite positive reported annual revenue and net income growth. See our latest analysis for Walker & Dunlop. At a share price of US$51.25, Walker & Dunlop’s recent 7 day share price return of 2.11% contrasts with a year to date share price decline of 12.72%, while the 1 year total shareholder...

Wondering if Altria Group at around US$72.19 is offering fair value or an opening for better returns? This article walks through what the current price really reflects. The stock has returned 3.8% over the last week, 2.9% over the last month, 26.0% year to date, 30.4% over the past year, 101.8% over three years and 114.1% over five years, which gives important context before comparing price to underlying value. Recent coverage has focused on Altria Group's ongoing position in the tobacco...

Hims & Hers Health, Inc. recently appointed Dr. Anant Vinjamoori as Chief Medical Officer of the Hims brand, bringing more than a decade of clinical and executive experience in internal medicine, primary care, longevity, and digital health leadership to guide its care models. His background in preventive and longevity care, peptide-based therapies, and AI-enabled clinician tools positions Hims & Hers to deepen medical rigor as it broadens into areas like weight management, hormone health,...